DIABACT UBT

This brand name is authorized in Austria, Finland, Hong Kong, Ireland, United Kingdom

Active ingredients

The drug DIABACT UBT contains one active pharmaceutical ingredient (API):

1 Urea ¹³C UNII W6KX9E6D8X - UREA C-13

13C-urea is administered in the course of the breath test. After oral ingestion the labelled urea reaches the gastric mucosa. In the presence of Helicobacter pylori the 13C-urea is metabolised by the enzyme urease of Helicobacter pylori. Read about Urea ¹³C

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DIABACT UBT Tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V04CX05		V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CX Other diagnostic agents
Discover more medicines within V04CX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 016874, 016937
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 93843, 93844
Country: HK	Department of Health Drug Office	Identifier(s): 49351